Analytic Investors’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-8,632
Closed -$242K 648
2015
Q4
$242K Sell
8,632
-12,077
-58% -$341K ﹤0.01% 587
2015
Q3
$505K Buy
+20,709
New +$495K 0.01% 455

Other funds holding IRMD

Analytic Investors's IRMD Position: Q1 2016 in Review

Analytic Investors sold out of iRadimed (IRMD) in Q1 2016, closing a stake of 8,632 shares — an estimated $242K sold.

Analytic Investors first reported a position in IRMD in Q3 2015 and held it in 2 quarters. The position peaked at $505K in Q3 2015. 66 funds tracked by Wall St. Rank hold IRMD as of Q1 2016.

  • Analytic Investors reported no remaining iRadimed position as of Q1 2016 after selling out during the quarter.
  • Analytic Investors sold 8,632 iRadimed shares in Q1 2016, an estimated $242K.
  • Analytic Investors first reported a position in iRadimed in Q3 2015 and held it in 2 quarters.
  • Analytic Investors's iRadimed position peaked at $505K in Q3 2015.
  • 66 funds tracked by Wall St. Rank held iRadimed as of Q1 2016.

Based on Analytic Investors's 13F filing for Q1 2016, filed 20 May 2016.